Biomet 8-K Biomet Announces Fourth Quarter and Fiscal 2008 Financial Results

Exhibit 99.3

Biomet, Inc.

Other Sales Information

Twelve Month Period Ended May 31, 2008

(In millions, unaudited)

	(Combined)* 2008		2007		Reported Growth %		Currency Growth %
Reconstructive	$	1,756.7	$	1,502.8	16.9	%	12.2	%
Fixation		230.3		226.4	1.7	%	-0.5	%
Spine		208.0		205.6	1.2	%	-0.1	%
Other		188.3		172.6	9.1	%	5.9	%
Total	$	2,383.3	$	2,107.4	13.1	%	9.1	%

	Sales Growth As Reported		FX Impact		Sales Growth in Local Currencies
Reconstructive	16.9	%	4.7	%	12.2	%
Fixation	1.7	%	2.2	%	-0.5	%
Spine	1.2	%	1.3	%	-0.1	%
Other	9.1	%	3.2	%	5.9	%
Total sales	13.1	%	4.0	%	9.1	%

	Sales Growth As Reported		FX Impact		Sales Growth in Local Currencies		Instrument Impact		Sales Growth Ex-instruments in Local Currencies
Reconstructive	16.9	%	4.7	%	12.2	%	0.8	%	13.0	%
Fixation	1.7	%	2.2	%	-0.5	%	N/A		N/A
Spine	1.2	%	1.3	%	-0.1	%	N/A		N/A
Other	9.1	%	3.2	%	5.9	%	N/A		N/A
Total sales	13.1	%	4.0	%	9.1	%	0.6	%	9.7	%

	Sales Growth As Reported		FX Impact		Sales Growth in Local Currencies		Instrument Impact		Sales Growth Ex-instruments in Local Currencies
Knees	19.1	%	3.9	%	15.2	%	1.4	%	16.6	%
Hips	13.5	%	4.6	%	8.9	%	0.7	%	9.6	%

* See Non-GAAP Financial Measures Disclosure Below for “Combined” Period Disclosed Herein.